154 related articles for article (PubMed ID: 1336422)
1. Alginate--its role in neutrophil responses and signal transduction towards mucoid Pseudomonas aeruginosa bacteria.
König B; Friedl P; Pedersen SS; König W
Int Arch Allergy Immunol; 1992; 99(1):98-106. PubMed ID: 1336422
[TBL] [Abstract][Full Text] [Related]
2. Antibody to Pseudomonas aeruginosa mucoid exopolysaccharide and to sodium alginate in cystic fibrosis serum.
Speert DP; Lawton D; Mutharia LM
Pediatr Res; 1984 May; 18(5):431-3. PubMed ID: 6233529
[TBL] [Abstract][Full Text] [Related]
3. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate).
Hatano K; Goldberg JB; Pier GB
Infect Immun; 1995 Jan; 63(1):21-6. PubMed ID: 7528730
[TBL] [Abstract][Full Text] [Related]
4. Hypochlorite scavenging by Pseudomonas aeruginosa alginate.
Learn DB; Brestel EP; Seetharama S
Infect Immun; 1987 Aug; 55(8):1813-8. PubMed ID: 3038752
[TBL] [Abstract][Full Text] [Related]
5. Nonspecific immunoglobulin synthesis and elevated IgG levels in rabbits immunized with mucoid exopolysaccharide from cystic fibrosis isolates of Pseudomonas aeruginosa.
Pier GB; Elcock ME
J Immunol; 1984 Aug; 133(2):734-9. PubMed ID: 6234359
[TBL] [Abstract][Full Text] [Related]
6. Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments.
Mai GT; Seow WK; Pier GB; McCormack JG; Thong YH
Infect Immun; 1993 Feb; 61(2):559-64. PubMed ID: 8423085
[TBL] [Abstract][Full Text] [Related]
7. Complement deposition by antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide (MEP) and by non-MEP specific opsonins.
Pier GB; Grout M; Desjardins D
J Immunol; 1991 Sep; 147(6):1869-76. PubMed ID: 1832427
[TBL] [Abstract][Full Text] [Related]
8. Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine.
Pier GB; DesJardin D; Grout M; Garner C; Bennett SE; Pekoe G; Fuller SA; Thornton MO; Harkonen WS; Miller HC
Infect Immun; 1994 Sep; 62(9):3972-9. PubMed ID: 8063415
[TBL] [Abstract][Full Text] [Related]
9. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
Pier GB
Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
[TBL] [Abstract][Full Text] [Related]
10. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing.
Leid JG; Willson CJ; Shirtliff ME; Hassett DJ; Parsek MR; Jeffers AK
J Immunol; 2005 Dec; 175(11):7512-8. PubMed ID: 16301659
[TBL] [Abstract][Full Text] [Related]
11. Cloning of genes controlling alginate biosynthesis from a mucoid cystic fibrosis isolate of Pseudomonas aeruginosa.
Darzins A; Chakrabarty AM
J Bacteriol; 1984 Jul; 159(1):9-18. PubMed ID: 6330052
[TBL] [Abstract][Full Text] [Related]
12. Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis.
Chotirmall SH; Smith SG; Gunaratnam C; Cosgrove S; Dimitrov BD; O'Neill SJ; Harvey BJ; Greene CM; McElvaney NG
N Engl J Med; 2012 May; 366(21):1978-86. PubMed ID: 22607135
[TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine.
Theilacker C; Coleman FT; Mueschenborn S; Llosa N; Grout M; Pier GB
Infect Immun; 2003 Jul; 71(7):3875-84. PubMed ID: 12819072
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa.
Pier GB; Matthews WJ; Eardley DD
J Infect Dis; 1983 Mar; 147(3):494-503. PubMed ID: 6220094
[TBL] [Abstract][Full Text] [Related]
15. Effects of mucoid and non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients on inflammatory mediator release from human polymorphonuclear granulocytes and rat mast cells.
Friedl P; König B; König W
Immunology; 1992 May; 76(1):86-94. PubMed ID: 1321094
[TBL] [Abstract][Full Text] [Related]
16. Effect of Pseudomonas aeruginosa alginate on Escherichia coli- and Staphylococcus aureus-induced inflammatory mediator release from human cells.
König B; Pedersen SS; König W
Int Arch Allergy Immunol; 1993; 100(2):144-50. PubMed ID: 7680255
[TBL] [Abstract][Full Text] [Related]
17. Roles of human peripheral blood leukocyte protein kinase C and G proteins in inflammatory mediator release by isogenic Escherichia coli strains.
König B; König W
Infect Immun; 1991 Oct; 59(10):3801-10. PubMed ID: 1654302
[TBL] [Abstract][Full Text] [Related]
18. Phagocytosis of mucoid and nonmucoid strains of Pseudomonas aeruginosa.
Meshulam T; Obedeanu N; Merzbach D; Sobel JD
Clin Immunol Immunopathol; 1984 Aug; 32(2):151-65. PubMed ID: 6428788
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa.
Stiver HG; Zachidniak K; Speert DP
Clin Invest Med; 1988 Aug; 11(4):247-52. PubMed ID: 2971496
[TBL] [Abstract][Full Text] [Related]
20. Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis.
Pier GB; Saunders JM; Ames P; Edwards MS; Auerbach H; Goldfarb J; Speert DP; Hurwitch S
N Engl J Med; 1987 Sep; 317(13):793-8. PubMed ID: 2957591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
